Effect of Milk Thistle on the Pharmacokinetics of Darunavir-Ritonavir in HIV-Infected Patients

Por Moltó, José, Valle, Marta, Miranda, Cristina, Cedeño, Samandhy, Negredo, Eugenia, Clotet, Bonaventura
Publicado em 2012

Herb-Drug Interaction between Echinacea purpurea and Etravirine in HIV-Infected Patients

Por Moltó, José, Valle, Marta, Miranda, Cristina, Cedeño, Samandhy, Negredo, Eugenia, Clotet, Bonaventura
Publicado em 2012

Population pharmacokinetic modelling of the changes in atazanavir plasma clearance caused by ritonavir plasma concentrations in HIV‐1 infected patients

Por Moltó, José, Estévez, Javier A., Miranda, Cristina, Cedeño, Samandhy, Clotet, Bonaventura, Valle, Marta
Publicado no Br J Clin Pharmacol (2016)

Minimal Removal of Raltegravir by Hemodialysis in HIV-Infected Patients with End-Stage Renal Disease

Por Moltó, José, Sanz-Moreno, José, Valle, Marta, Cedeño, Samandhy, Bonal, Jordi, Bouarich, Hanane, Clotet, Bonaventura
Publicado em 2010

Herb-Drug Interaction between Echinacea purpurea and Darunavir-Ritonavir in HIV-Infected Patients

Por Moltó, José, Valle, Marta, Miranda, Cristina, Cedeño, Samandhy, Negredo, Eugenia, Barbanoj, Manuel José, Clotet, Bonaventura
Publicado em 2011

P-glycoprotein (ABCB1) activity decreases raltegravir disposition in primary CD4+P-gp(high) cells and correlates with HIV-1 viral load

Por Minuesa, Gerard, Arimany-Nardi, Cristina, Erkizia, Itziar, Cedeño, Samandhy, Moltó, José, Clotet, Bonaventura, Pastor-Anglada, Marçal, Martinez-Picado, Javier
Publicado no J Antimicrob Chemother (2016)

Plasma and Intracellular (Peripheral Blood Mononuclear Cells) Pharmacokinetics of Once-Daily Raltegravir (800 Milligrams) in HIV-Infected Patients

Por Moltó, José, Valle, Marta, Back, David, Cedeño, Samandhy, Watson, Victoria, Liptrott, Neill, Egan, Deirdre, Miranda, Cristina, Barbanoj, Manuel J., Clotet, Bonaventura
Publicado em 2011

Darunavir Inhibitory Quotient Predicts the 48-Week Virological Response to Darunavir-Based Salvage Therapy in Human Immunodeficiency Virus-Infected Protease Inhibitor-Experienced P...

Por Moltó, José, Santos, José R., Pérez-Álvarez, Nuria, Cedeño, Samandhy, Miranda, Cristina, Khoo, Saye, Else, Laura, Llibre, Josep Maria, Valle, Marta, Clotet, Bonaventura
Publicado em 2008

Immune Screening Identifies Novel T Cell Targets Encoded by Antisense Reading Frames of HIV-1

Por Berger, Christoph T., Llano, Anuska, Carlson, Jonathan M., Brumme, Zabrina L., Brockman, Mark A., Cedeño, Samandhy, Harrigan, P. Richard, Kaufmann, Daniel E., Heckerman, David, Meyerhans, Andreas, Brander, Christian
Publicado no J Virol (2015)

Variants in the CYP7B1 gene region do not affect natural resistance to HIV-1 infection

Por Sironi, Manuela, Biasin, Mara, Pontremoli, Chiara, Cagliani, Rachele, Saulle, Irma, Trabattoni, Daria, Vichi, Francesca, Lo Caputo, Sergio, Mazzotta, Francesco, Aguilar-Jimenez, Wbeimar, Rugeles, Maria Teresa, Cedeno, Samandhy, Sanchez, Jorge, Brander, Christian, Clerici, Mario
Publicado no Retrovirology (2015)

Direct Interrogation of Viral Peptides Presented by the Class I HLA of HIV-Infected T Cells

Por Yaciuk, Jane C., Skaley, Matthew, Bardet, Wilfried, Schafer, Fredda, Mojsilovic, Danijela, Cate, Steven, Stewart, Christopher J., McMurtrey, Curtis, Jackson, Kenneth W., Buchli, Rico, Olvera, Alex, Cedeño, Samandhy, Plana, Montserrat, Mothe, Beatriz, Brander, Christian, West, John T., Hildebrand, William H.
Publicado no J Virol (2014)

Defining the HLA class I‐associated viral antigen repertoire from HIV‐1‐infected human cells

Por Ternette, Nicola, Yang, Hongbing, Partridge, Thomas, Llano, Anuska, Cedeño, Samandhy, Fischer, Roman, Charles, Philip D., Dudek, Nadine L., Mothe, Beatriz, Crespo, Manuel, Fischer, William M., Korber, Bette T. M., Nielsen, Morten, Borrow, Persephone, Purcell, Anthony W., Brander, Christian, Dorrell, Lucy, Kessler, Benedikt M., Hanke, Tomáš
Publicado no Eur J Immunol (2015)